News
IIT researchers to re-purpose approved drugs from DrugBank database for treating COVID-19 by targeting SARS-CoV-2 main protease
Taking advantage of available crystal structure of the SARS-CoV-2 main protease, a structure-based inhibitor design will be done by the researchers from the available FDA approved drugs compounds in the DrugBank database.
DST initiates COVID-19 India National Supermodel for monitoring infection transmission & aid decision-making by policymakers
DST has initiated this exercise to pool in expertise in the field and create one model for the entire country that will be subjected to rigorous tests required for evidence-based forecasting.
CCMB researchers culture novel coronavirus; research may help in drug testing and vaccine development
Virologists at CCMB have isolated infectious viruses from several isolates. The ability to culture the virus in lab enables CCMB to work towards vaccine development.
Sun Pharma receives approval from DCGI to initiate clinical trial with Nafamostat in Covid-19 patients
Nafamostat has been identified as a potential candidate for Covid-19 patients by scientists at University of Tokyo and Leibniz Institute for Primate Research, Germany
voice for BT and BEST 2026
